Company Profiles

driven by the PitchBook Platform

Adjuvance Technologies

Description

Owner and operator of a biopharmaceutical company. The company designs and offers vaccine to empower global health.

Angel

Latest Deal Type

$2.72M

Latest Deal Amount

$2.72M

Total Amount Raised

1

Investors

Description

Owner and operator of a biopharmaceutical company. The company designs and offers vaccine to empower global health.

Website:

www.adjuvancetechnologies.com

Ownership Status

Privately held (no backing)

Financing Status

Pending Transaction (Angel)

Primary Industry

Other Pharmaceuticals and Biotechnology

Primary Office

116 West 22nd Street 6th Floor New York, NY 10010United States
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Adjuvance Technologies's full profile, request a free trial.

    Adjuvance Technologies Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Adjuvance Technologies Investors (1)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    U.S. Department of Health and Human ServicesGovernment000 0000000 0000
    U.S. Department of Health and Human Services Government

    Adjuvance Technologies Executive Team (2)

    NameTitleBoard
    Seat
    Contact
    Info
    Jeffrey GardnerCo-Founder, Chief Operating Officer, President, Chief Executive Officer and Board Member
    Philip Livingston MDCo-Founder, Board Member and Chief Scientific Officer
    Jeffrey Gardner Co-Founder, Chief Operating Officer, President, Chief Executive Officer and Board Member
    Philip Livingston MD Co-Founder, Board Member and Chief Scientific Officer

    Adjuvance Technologies Board Members (6)

    NameRepresentingRoleSinceContact
    Info
    Christopher Frigon JDSelfBoard Member and Corporate Secretary000 0000
    David Gin Ph.DAdjuvance TechnologiesCo-Founder & Board Member000 0000
    Gregory PolandAdjuvance TechnologiesBoard Member000 0000
    John GalloAdjuvance TechnologiesBoard Member000 0000
    Mary GinAdjuvance TechnologiesBoard Member000 0000
    Christopher Frigon JD Board Member and Corporate Secretary Self
    David Gin Ph.D Co-Founder & Board Member Adjuvance Technologies
    Gregory Poland Board Member Adjuvance Technologies
    John Gallo Board Member Adjuvance Technologies
    Mary Gin Board Member Adjuvance Technologies
    Request full access to PitchBook